{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:04:06Z","timestamp":1793318646482,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T00:00:00Z","timestamp":1487808000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00391-017-1197-3","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T11:09:55Z","timestamp":1487848195000},"page":"453-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Crystal arthritides \u2013 gout and calcium pyrophosphate arthritis","Kristallarthritiden \u2013 Gicht und Kalziumpyrophosphat-Arthritis"],"prefix":"10.1007","volume":"51","author":[{"given":"S.","family":"Schlee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. C.","family":"Bollheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"H\u00e4rle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"1197_CR1","first-page":"352","volume":"68","author":"KJ Bhansing","year":"2010","unstructured":"Bhansing KJ, Van Bon L, Janssen M et\u00a0al (2010) Gout: A\u00a0clinical syndrome illustrated and discussed. Neth J Med 68:352\u2013359","journal-title":"Neth J Med"},{"key":"1197_CR2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/art.27338","volume":"62","author":"V Bhole","year":"2010","unstructured":"Bhole V, De Vera M, Rahman MM et al (2010) Epidemiology of gout in women: Fifty-two-year followup of a\u00a0prospective cohort. Arthritis Rheum 62:1069\u20131076","journal-title":"Arthritis Rheum"},{"key":"1197_CR3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00281-013-0384-6","volume":"35","author":"N Branzk","year":"2013","unstructured":"Branzk N, Papayannopoulos V (2013) Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol 35:513\u2013530","journal-title":"Semin Immunopathol"},{"key":"1197_CR4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2952","volume":"12","author":"N Busso","year":"2010","unstructured":"Busso N, So A (2010) Mechanisms of inflammation in gout. Arthritis Res Ther 12:206","journal-title":"Arthritis Res Ther"},{"key":"1197_CR5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","volume":"363","author":"HK Choi","year":"2004","unstructured":"Choi HK, Atkinson K, Karlson EW et\u00a0al (2004) Alcohol intake and risk of incident gout in men: a\u00a0prospective study. Lancet 363:1277\u20131281","journal-title":"Lancet"},{"key":"1197_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.39449.819271.BE","volume":"336","author":"HK Choi","year":"2008","unstructured":"Choi HK, Curhan G (2008) Soft drinks, fructose consumption, and the risk of gout in men: Prospective cohort study. BMJ 336:309\u2013312","journal-title":"BMJ"},{"key":"1197_CR7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.7326\/0003-4819-143-7-200510040-00009","volume":"143","author":"HK Choi","year":"2005","unstructured":"Choi HK, Mount DB, Reginato AM et\u00a0al (2005) Pathogenesis of gout. Ann Intern Med 143:499\u2013516","journal-title":"Ann Intern Med"},{"key":"1197_CR8","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1001\/jama.2010.1638","volume":"304","author":"HK Choi","year":"2010","unstructured":"Choi HK, Willett W, Curhan G (2010) Fructose-rich beverages and risk of gout in women. JAMA 304:2270\u20132278","journal-title":"JAMA"},{"key":"1197_CR9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10557-014-6538-5","volume":"28","author":"CR Chong","year":"2014","unstructured":"Chong CR, Chan WP, Nguyen TH et al (2014) Thioredoxin-interacting protein: Pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes. Cardiovasc Drugs Ther 28:347\u2013360","journal-title":"Cardiovasc Drugs Ther"},{"key":"1197_CR10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2217\/bmm.10.94","volume":"4","author":"S Cipriani","year":"2010","unstructured":"Cipriani S, Chen X, Schwarzschild MA (2010) Urate: a\u00a0novel biomarker of Parkinson\u2019s disease risk, diagnosis and prognosis. Biomark Med 4:701\u2013712","journal-title":"Biomark Med"},{"key":"1197_CR11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/9781420020632-16","volume-title":"Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes","author":"NHD Dalbeth","year":"2006","unstructured":"Dalbeth NHD (2006) Pathophysiology of crystal-induced arthritis. In: Wortmann RLSHJ, Becker MA, Ryan LM (eds) Crystal-Induced Arthropathies: Gout, Pseudogout, and Apatite-Associated Syndromes. Taylor & Francis Group, New York, p 239"},{"issue":"Suppl 5","key":"1197_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3949\/ccjm.75.Suppl_5.S13","volume":"75","author":"NL Edwards","year":"2008","unstructured":"Edwards NL (2008) The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med 75(Suppl 5):13\u201316","journal-title":"Cleve Clin J Med"},{"key":"1197_CR13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.410320616","volume":"32","author":"S Fahn","year":"1992","unstructured":"Fahn S, Cohen G (1992) The oxidant stress hypothesis in Parkinson\u2019s disease: Evidence supporting it. Ann Neurol 32:804\u2013812","journal-title":"Ann Neurol"},{"key":"1197_CR14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"DI Feig","year":"2008","unstructured":"Feig DI, Soletsky B, Johnson RJ (2008) Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: A\u00a0randomized trial. JAMA 300:924\u2013932","journal-title":"JAMA"},{"key":"1197_CR15","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.10611","volume":"54","author":"MA Hernan","year":"2003","unstructured":"Hernan MA, Chen H, Schwarzschild MA et\u00a0al (2003) Alcohol consumption and the incidence of Parkinson\u2019s disease. Ann Neurol 54:170\u2013175","journal-title":"Ann Neurol"},{"key":"1197_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1126\/science.289.5477.265","volume":"289","author":"AM Ho","year":"2000","unstructured":"Ho AM, Johnson MD, Kingsley DM (2000) Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289:265\u2013270","journal-title":"Science"},{"key":"1197_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","volume":"62","author":"SY Kim","year":"2010","unstructured":"Kim SY, Guevara JP, Kim KM et al (2010) Hyperuricemia and coronary heart disease: A\u00a0systematic review and meta-analysis. Arthritis Care Res (Hoboken) 62:170\u2013180","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1197_CR18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13075-015-0842-8","volume":"17","author":"JC Lin","year":"2015","unstructured":"Lin JC, Lin CL, Chen MC et\u00a0al (2015) Gout, not hyperuricemia alone, impairs left ventricular diastolic function. Arthritis Res Ther 17:323","journal-title":"Arthritis Res Ther"},{"key":"1197_CR19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/kep069","volume":"48","author":"AJ Luk","year":"2009","unstructured":"Luk AJ, Levin GP, Moore EE et\u00a0al (2009) Allopurinol and mortality in hyperuricaemic patients. Rheumatology (Oxford) 48:804\u2013806","journal-title":"Rheumatology (Oxford)"},{"key":"1197_CR20","first-page":"199","volume":"63","author":"PPG Marson","year":"2011","unstructured":"Marson PPG (2011) Some historical remarks on microcrystalline arthritis (gout and chondrocalcinosis). Reumatismo 63:199\u2013206","journal-title":"Reumatismo"},{"key":"1197_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237\u2013241","journal-title":"Nature"},{"key":"1197_CR22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2008.11.001","volume":"83","author":"H Matsuo","year":"2008","unstructured":"Matsuo H, Chiba T, Nagamori S et\u00a0al (2008) Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia. Am J Hum Genet 83:744\u2013751","journal-title":"Am J Hum Genet"},{"key":"1197_CR23","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1038\/srep03755","volume":"4","author":"H Matsuo","year":"2014","unstructured":"Matsuo H, Nakayama A, Sakiyama M et\u00a0al (2014) ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci Rep 4:3755","journal-title":"Sci Rep"},{"key":"1197_CR24","doi-asserted-by":"crossref","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","volume":"1","author":"H Matsuo","year":"2009","unstructured":"Matsuo H, Takada T, Ichida K et al (2009) Common defects of ABCG2, a\u00a0high-capacity urate exporter, cause gout: A\u00a0function-based genetic analysis in a\u00a0Japanese population. Sci Transl Med 1:5ra11","journal-title":"Sci Transl Med"},{"key":"1197_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/ard.2004.024091","volume":"64","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Farrar JT, Bilker WB et\u00a0al (2005) Gout epidemiology: Results from the UK General Practice Research Database, 1990\u20131999. Ann Rheum Dis 64:267\u2013272","journal-title":"Ann Rheum Dis"},{"key":"1197_CR26","doi-asserted-by":"crossref","first-page":"e29318","DOI":"10.1371\/journal.pone.0029318","volume":"6","author":"I Mitroulis","year":"2011","unstructured":"Mitroulis I, Kambas K, Chrysanthopoulou A et al (2011) Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout. PLOS ONE 6:e29318","journal-title":"PLOS ONE"},{"key":"1197_CR27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","volume":"364","author":"T Neogi","year":"2011","unstructured":"Neogi T (2011) Clinical practice. Gout. N\u00a0Engl J Med 364:443\u2013452","journal-title":"N Engl J Med"},{"key":"1197_CR28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrmicro1815","volume":"6","author":"MG Netea","year":"2008","unstructured":"Netea MG, Brown GD, Kullberg BJ et\u00a0al (2008) An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6:67\u201378","journal-title":"Nat Rev Microbiol"},{"key":"1197_CR29","first-page":"221","volume":"63","author":"F Oliviero","year":"2011","unstructured":"Oliviero F, Scanu A, Punzi L (2011) Metabolism of crystals within the joint. Reumatismo 63:221\u2013229","journal-title":"Reumatismo"},{"key":"1197_CR30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/mds.25050","volume":"27","author":"N Palacios","year":"2012","unstructured":"Palacios N, Gao X, O\u2019reilly E et\u00a0al (2012) Alcohol and risk of Parkinson\u2019s disease in a\u00a0large, prospective cohort of men and women. Mov Disord 27:980\u2013987","journal-title":"Mov Disord"},{"key":"1197_CR31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2009.07.011","volume":"30","author":"V Papayannopoulos","year":"2009","unstructured":"Papayannopoulos V, Zychlinsky A (2009) NETs: a\u00a0new strategy for using old weapons. Trends Immunol 30:513\u2013521","journal-title":"Trends Immunol"},{"key":"1197_CR32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1107\/S1744309111010347","volume":"67","author":"G Polekhina","year":"2011","unstructured":"Polekhina G, Ascher DB, Kok SF et al (2011) Crystallization and preliminary X\u2011ray analysis of the N\u2011terminal domain of human thioredoxin-interacting protein. Acta Crystallogr Sect F Struct Biol Cryst Commun 67:613\u2013617","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"1197_CR33","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrrheum.2012.144","volume":"8","author":"AM Reginato","year":"2012","unstructured":"Reginato AM, Mount DB, Yang I et\u00a0al (2012) The genetics of hyperuricaemia and gout. Nat Rev Rheumatol 8:610\u2013621","journal-title":"Nat Rev Rheumatol"},{"key":"1197_CR34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/CIA.S5476","volume":"5","author":"MK Reinders","year":"2010","unstructured":"Reinders MK, Jansen TL (2010) Management of hyperuricemia in gout: Focus on febuxostat. Clin Interv Aging 5:7\u201318","journal-title":"Clin Interv Aging"},{"key":"1197_CR35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar3199","volume":"12","author":"E Roddy","year":"2010","unstructured":"Roddy E, Doherty M (2010) Epidemiology of gout. Arthritis Res Ther 12:223","journal-title":"Arthritis Res Ther"},{"key":"1197_CR36","doi-asserted-by":"crossref","first-page":"R154","DOI":"10.1186\/ar4337","volume":"15","author":"AK Rosenthal","year":"2013","unstructured":"Rosenthal AK, Gohr CM, Mitton-Fitzgerald E et al (2013) The progressive ankylosis gene product ANK regulates extracellular ATP levels in primary articular chondrocytes. Arthritis Res Ther 15:R154","journal-title":"Arthritis Res Ther"},{"key":"1197_CR37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","volume":"20","author":"C Schauer","year":"2014","unstructured":"Schauer C, Janko C, Munoz LE et\u00a0al (2014) Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med 20:511\u2013517","journal-title":"Nat Med"},{"key":"1197_CR38","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1136\/ard.2010.128454","volume":"69","author":"N Schlesinger","year":"2010","unstructured":"Schlesinger N, Thiele RG (2010) The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 69:1907\u20131912","journal-title":"Ann Rheum Dis"},{"key":"1197_CR39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01991","volume":"425","author":"Y Shi","year":"2003","unstructured":"Shi Y, Evans JE, Rock KL (2003) Molecular identification of a\u00a0danger signal that alerts the immune system to dying cells. Nature 425:516\u2013521","journal-title":"Nature"},{"issue":"720","key":"1197_CR40","first-page":"722","volume":"3","author":"A So","year":"2007","unstructured":"So A (2007) Recent advances in the pathophysiology of hyperuricemia and gout. Rev Med Suisse 3(720):722\u2013724","journal-title":"Rev Med Suisse"},{"key":"1197_CR41","first-page":"187","volume":"70","author":"P Tan","year":"2011","unstructured":"Tan P, Hyndman D, Liu S (2011) Lesinurad (RDEA594), a\u00a0novel investigational uricosuric agent for hyperuricemia and gout, blocks transport of uric acid induced by hydrochlorothiazide. Ann Rheum Dis 70:187","journal-title":"Ann Rheum Dis"},{"key":"1197_CR42","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","volume":"349","author":"RA Terkeltaub","year":"2003","unstructured":"Terkeltaub RA (2003) Clinical practice. Gout. N\u00a0Engl J Med 349:1647\u20131655","journal-title":"N Engl J Med"},{"key":"1197_CR43","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3899\/jrheum.140126","volume":"41","author":"RJ Torres","year":"2014","unstructured":"Torres RJ, De Miguel E, Bailen R et\u00a0al (2014) Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion. J\u00a0Rheumatol 41:1863\u20131870","journal-title":"J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-017-1197-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-017-1197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-017-1197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T16:56:18Z","timestamp":1719075378000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-017-1197-3"}},"subtitle":["Part\u00a01: Epidemiology and pathophysiology","Teil\u00a01: Epidemiologie und Pathophysiologie"],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["1197"],"URL":"https:\/\/doi.org\/10.1007\/s00391-017-1197-3","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"value":"0948-6704","type":"print"},{"value":"1435-1269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}